CD274 and neoplasm: Chronic or aberrant activation can lead to sustained inflammation, upregulation of PD-L1, and infiltration of myeloid-derived suppressor cells (MDSCs), all of which contribute to immune tolerance and tumor immune evasion (95, 99).